Maxillary Patient Specific Implants in Bimaxillary Orthognathic Surgery
Launched by ESBJERG HOSPITAL - UNIVERSITY HOSPITAL OF SOUTHERN DENMARK · Mar 4, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a type of jaw surgery called orthognathic surgery, which is used to correct issues with the jaw, such as retrognathia (a condition where the lower jaw is positioned further back than normal) and malocclusion (improper bite alignment). The researchers want to compare two methods of fixing the jaw: one that uses a 3D-printed guide (called a splint) and metal plates, and another that uses specially designed 3D-printed implants made of titanium. The goal is to see if the patient-specific implants (PSIs) are more accurate and stable in holding the jaw bones in place after surgery compared to the conventional method.
To be eligible for this trial, participants should have certain jaw conditions and be undergoing a specific type of jaw surgery called a three-piece Le Fort I osteotomy, which may also include chin surgery. Participants can expect to receive the standard surgical treatment as part of their orthodontic care, and the researchers will follow up with them to see how well the PSIs work over time. This study is important because it could help improve outcomes for patients needing jaw surgery by determining which method provides better results.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Mandibular retrognathia
- • Occlusion class II
- • Three-piece Le Fort I osteotomy, as part of bimaxillary orthognathic surgery with or without genioplasty
- Exclusion Criteria:
- • Cleft lip
- • Craniofacial syndromes
- • Former trauma
- • Obstructive sleep apnea
About Esbjerg Hospital University Hospital Of Southern Denmark
Esbjerg Hospital, part of the University Hospital of Southern Denmark, is a leading clinical research institution dedicated to advancing healthcare through innovative research and comprehensive patient care. With a focus on multidisciplinary collaboration and state-of-the-art facilities, the hospital conducts a wide range of clinical trials aimed at improving treatment outcomes and enhancing patient quality of life. Its commitment to scientific excellence and ethical standards positions Esbjerg Hospital as a pivotal contributor to the advancement of medical knowledge and the development of new therapies in southern Denmark and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Esbjerg, , Denmark
Patients applied
Trial Officials
Else M Pinholt, dr.odont.
Study Chair
University Hospital of Southern Denmark, Esbjerg
Alexandru Diaconu, m.sc.
Principal Investigator
University Hospital of Southern Denmark, Esbjerg
Michael B Holte, ph.d.
Study Director
University Hospital of Southern Denmark, Esbjerg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported